{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-008821","form_type":"8-K","ticker":"ODYY","cik":"0001626644","company_name":"Odyssey Health, Inc.","filed_at":"2023-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.832072+00:00","generated_at":"2026-06-07T13:30:00.939677+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Odyssey Health shareholders approve asset sale to Oragenics for $1M cash + 8M shares","bullets":["Stockholders voted 45,032,700 for, 382,191 against the asset sale to Oragenics.","$1M total cash consideration: $500k paid on signing, second $500k paid after shareholder approval on Dec 11.","Upon closing, Odyssey will receive 8M shares of Oragenics Convertible Preferred Class F stock (1:1 conversion to common).","Transaction expected to close before end of 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-008821","json":"https://secwatch.observer/filing/0001683168-23-008821.json","markdown":"https://secwatch.observer/filing/0001683168-23-008821.md","text":"https://secwatch.observer/filing/0001683168-23-008821.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626644/000168316823008821/0001683168-23-008821-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626644/000168316823008821/odyssey_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T13:30:00.939677+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}